Literature DB >> 19932144

Temporal-spatial expression of presenilin 1 and the production of amyloid-beta after acute spinal cord injury in adult rat.

S Kobayashi1, T Sasaki, T Katayama, T Hasegawa, A Nagano, K Sato.   

Abstract

Regulated intramembrane proteolysis (RIP) is one of the signaling pathways mediating information transfer from the extracellular to the intracellular domain. gamma-Secretase is an aspartyl protease of the RIP that cleaves the intramembrane region of type I integral membrane proteins, such as amyloid precursor protein (APP). Presenilin 1 (PS1) is the catalytic subunit of gamma-secretase and PS1 mutations cause Alzheimer's disease, spastic paraplegia and spinal cord atrophy. The biological function of PS1 in the spinal cord has not been fully elucidated. Thus, to clarify the involvement of RIP in spinal cord injury, we examined the expression of PS1, APP and amyloid-beta protein (Abeta) following rat spinal cord hemisection. Western blot analysis showed that PS1, APP and Abeta levels increased 1 day after spinal cord hemisection. Immunohistochemistry showed an increased number of PS1 immunopositive cells about 1mm from the lesion site. PS1, APP and Abeta double staining with cell-type specific markers showed colocalization of PS1 with axons in the white matter of the lesioned side. These findings suggest that RIP signaling occurs following rat spinal cord injury. In the future, the control of RIP may offer a new strategy for the treatment of spinal cord injury. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19932144     DOI: 10.1016/j.neuint.2009.11.005

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  9 in total

1.  Inhibition of amyloid precursor protein secretases reduces recovery after spinal cord injury.

Authors:  Ahdeah Pajoohesh-Ganji; Mark P Burns; Sonali Pal-Ghosh; Gauri Tadvalkar; Nicole G Hokenbury; Mary Ann Stepp; Alan I Faden
Journal:  Brain Res       Date:  2014-03-11       Impact factor: 3.252

Review 2.  Exosomes in Acquired Neurological Disorders: New Insights into Pathophysiology and Treatment.

Authors:  Nicole Osier; Vida Motamedi; Katie Edwards; Ava Puccio; Ramon Diaz-Arrastia; Kimbra Kenney; Jessica Gill
Journal:  Mol Neurobiol       Date:  2018-04-16       Impact factor: 5.590

3.  Effects of the Notch Signaling Pathway on Secondary Brain Changes Caused by Spinal Cord Injury in Mice.

Authors:  Chengcai Li; Shaoxin Huang; Wu Zhou; Zhiping Xie; Shenke Xie; Meihua Li
Journal:  Neurochem Res       Date:  2022-02-24       Impact factor: 3.996

4.  Temporospatial expression of fibulin-1 after acute spinal cord injury in rats.

Authors:  Guanhua Xu; Ying Cui; Lingling Wang; Jinlong Zhang; Aiguo Shen; Weidong Li; Guofeng Bao; Yuyu Sun; Zhiming Cui
Journal:  J Spinal Cord Med       Date:  2014-06-26       Impact factor: 1.985

5.  Spinal cord injury and Alzheimer's disease risk: a population-based, retrospective cohort study.

Authors:  Tian-Shin Yeh; Yu-Chun Ho; Cherng-Lan Hsu; Shin-Liang Pan
Journal:  Spinal Cord       Date:  2017-10-23       Impact factor: 2.772

6.  Modulation of ABCA1 by an LXR agonist reduces β-amyloid levels and improves outcome after traumatic brain injury.

Authors:  David J Loane; Patricia M Washington; Lilit Vardanian; Ana Pocivavsek; Hyang-Sook Hoe; Karen E Duff; Ibolja Cernak; G William Rebeck; Alan I Faden; Mark P Burns
Journal:  J Neurotrauma       Date:  2011-02       Impact factor: 5.269

7.  Soluble β-amyloid Precursor Protein Alpha binds to p75 neurotrophin receptor to promote neurite outgrowth.

Authors:  Noriko Hasebe; Yuki Fujita; Masaki Ueno; Kazuhiro Yoshimura; Yuji Fujino; Toshihide Yamashita
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

Review 8.  The Ubiquitin-Proteasome System: Potential Therapeutic Targets for Alzheimer's Disease and Spinal Cord Injury.

Authors:  Bing Gong; Miroslav Radulovic; Maria E Figueiredo-Pereira; Christopher Cardozo
Journal:  Front Mol Neurosci       Date:  2016-01-26       Impact factor: 5.639

9.  The amyloid precursor protein derivative, APP96-110, is efficacious following intravenous administration after traumatic brain injury.

Authors:  Stephanie L Plummer; Frances Corrigan; Emma Thornton; Joshua A Woenig; Robert Vink; Roberto Cappai; Corinna Van Den Heuvel
Journal:  PLoS One       Date:  2018-01-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.